DBI — Deutsche Biotech Innovativ AG Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Deutsche Biotech Innovativ Says Adrenomed's Antibody Adrecizumab From Shows Positive Effect In COVID-19 Patients
Brief: Deutsche Biotech Innovativ Signs Convertible Loan Agreement With SphingoTec
Brief: Deutsche Biotech Innovativ: Three Main Shareholders Divest Up To 15% Of Shares
Brief: Deutsche Biotech Innovativ Appoints Ralf M. Jakobs As New CFO